Showing results (321-330 of 350) with videos related to
Sort By:
Pageof 35
JAMA Ophthalmology|April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.Journal of Diabetes Science and Technology|March 18, 2024
Cost-Effectiveness of Closed-Loop Automated Insulin Delivery Using the Cambridge Hybrid Algorithm in Children and Adolescents with Type 1 Diabetes: Results from a Multicenter 6-Month Randomized TrialD Steven Fox, Julia Ware, Charlotte K Boughton, et al.JAMA Ophthalmology|July 13, 2023
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical TrialMichael X Repka, Katherine K Weise, Danielle L Chandler, et al.Journal of Diabetes Science and Technology|April 10, 2013
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profileRichard M Bergenstal, Andrew J Ahmann, Timothy Bailey, et al.Diabetes Technology & Therapeutics|December 17, 2016
Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin DeliveryBoris Kovatchev, Peiyao Cheng, Stacey M Anderson, et al.Diabetes Care|May 31, 2020
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled TrialSue A Brown, Roy W Beck, Dan Raghinaru, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|July 16, 2003
High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Jonathan D Trobe, Pamela S Moke, et al.Archives of Neurology|September 15, 2004
Neurologic impairment 10 years after optic neuritisRoy W Beck, Craig H Smith, Robin L Gal, et al.American Journal of Ophthalmology|January 1, 2004
Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trialRoy W Beck, Robin L Gal, M Tariq Bhatti, et al.Diabetes Technology & Therapeutics|March 2, 2013
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)Richard M Bergenstal, Andrew J Ahmann, Timothy Bailey, et al.Pageof 35